Coagulation analyzer ACL TOP 350 CTS, manufacturer: Werfen, USA

• Barcoded reagents
• Continuous built-in reagent stability monitoring
• Automatic execution of quality control frequency
• Re-testing and reflex testing capabilities
• Fully automated reporting of factor analyses with parallelism
• Automatic verification and uploading of results
• Sampling from a closed tube by piercing the cap (CTS models only)

• Continuous loading and unloading of samples and reagents through racks without system interruption
• Continuous cuvette loading and waste disposal

• Daily maintenance requested by the user and performed by the system in < 5 minutes
• "Overdue maintenance" notifications to alert the user
• Remote tool diagnostics and troubleshooting via web in real time* (optional)

• Follows CLSI guidelines (AUTO 1–5) for true “reference point” sampling
• Open system compatible with most laboratory automated tracking systems
• Eliminates the need for expensive and slow robotic interface

• Up to 360 PT/hour
• PT results from standby mode in approximately 3 minutes
• Samples loaded on any rack, in any position, at any time, including STAT

• Detects interference from hemolysis, bilirubin or lipemia

- Values ​​exceeding analysis-specific thresholds are highlighted

- Pre-better on validated thresholds with optional customization

• Detects tube fill height issues
• Signals abnormal sample aspiration, prompting the user to check for clots

• The most comprehensive set of audit trail tools
• Time, date and operator stamps for all analyzer functions and activities
• Maintenance, quality control and calibration logs, as well as temperature reporting
• Comprehensive and secure audit reports with one click

• Second level password and electronic signature
• Automatic logout
• Restricting access to the system with user-specific login and password
• Automatic password expiration
• Complete 21 CFR Part 11 support tools
• Optionally restrict user access to patient demographic information

The ACL TOP Family 50 Series systems are optimized to work with a wide range of HemosIL assays. Together, they provide a complete disease management solution. Innovative HemosIL assays, from routine to specialized, help guide pathways to better patient care, which can reduce costs associated with length of stay and therapeutic management.